World leading targeted genomic newborn screening
Atlas uses targeted gene sequencing to enable high quality, high throughput, cost effective testing.
WHAT is ATLAS?
Technically validated,
high throughput, cost effective next generation newborn screening
Atlas can be incorporated into newborn screening programs today.
Heel prick bloodspot sample
Treatable childhood conditions
targeted genomic analysis & reporting software
Australian designed & developed
How does it work?
When designing a screening test, less is more.
Atlas uses targeted genomics to sidestep the challenges of whole genome/exome sequencing.
“An automated targeted gene sequencing laboratory workflow and purpose designed bioinformatics pipeline for newborn screening of genetic conditions can achieve high throughput testing, a clinically relevant turnaround time, and excellent analytical performance”
Development funded by
How is it different?
Targeted Genomic Newborn Screening
| Atlas Targeted Newborn Screening | Whole Genome/Exome Newborn Screening | |
|---|---|---|
| Genes sequenced | Customisable, from 1 to 132 | > 20,000 untargeted |
| Cost | Cost effective | Higher than targeted sequencing |
| Analytical performance | Sensitivty & specifcity >99% | Sensitivty & specifcity not published |
| Throughput | High | Low |
| Potential for uncertainties and incidental/secondary findings | Low, removed due to panel design | High |
| Implementation | Ready | In research phase |
We thought it was a no-brainer. Preventive health is the way of the future, why wouldn’t you use the latest technology to screen your children?
Karyn Henner / Read Full Article